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Case presentation
A 36-year-old HIV-positive woman with a CD4 count of 
13 cells/µl was admitted to the intensive care unit (ICU) 
at King Edward VIII Hospital, Durban, with a 3-week his-
tory of shortness of breath (New York Heart Association 
grade IV) which had progressively worsened 4 days prior 
to admission. She also had a 2-day history of pleuritic 
chest pain and cough. There was no past history of tu-
berculosis (TB) or TB contact. The medical and surgical 
history was non-contributory. Clinically, the patient was 
noted to be well nourished, with a body mass index >25 
kg/m2, febrile and tachypnoeic. There were no herpetic 
lesions on her lips or mouth. She was in severe respi-
ratory distress and chest auscultation revealed global 
crepitations with increased intensity at the bases of the 
lungs. The cardiac and abdominal examinations were 
normal. The patient was alert and orientated with no 
features of meningism.
Arterial blood gas analysis revealed severe type I res-
piratory failure with a PO2 4.5 kpa, PCO2 3.5 kpa and 
oxygen saturation 75%. The chest radiograph showed 
bilateral homogeneous opacities and a ground-glass 
appearance. In light of these findings the patient was 
intubated, ventilated and started empirically on intra-
venous amoxicillin-clavulanic acid and gentamycin. The 
haemoglobin concentration was 12.3 g/dl, the white 
cell count 8.0×109/l and the platelet count 249×109/l. 
Electrolyte levels and renal function were normal. Liver 
function tests showed a decreased albumin level of 19 
g/l and an increased gamma-glutaryltransferase (GGT) 
level of 125 IU/l. A bacterial and fungal septic screen was 
performed on blood, urine and endotracheal aspirate 
(ETA) samples. The diagnosis of PCP was confirmed by 
immunofluorescent testing (Axis; Shield Diagnostics Ltd, 
UK) on the ETA samples, which were also negative for 
routine bacterial pathogens and TB. Trimethoprim (TMP) 
240 mg-sulphamethoxazole (SMX) 2 400 mg 6-hourly 
intravenously and prednisone 40 mg intravenously daily 
were started; however, over the next few days there was 
no improvement in her clinical condition. Blood and ETA 
samples were obtained to exclude infection with atypi-
cal bacteria and viruses. She was started empirically on 
piperacillin-tazobactam and amikacin for suspected no-
socomial sepsis. Viral studies revealed a positive HSV-1 
DNA polymerase chain reaction (PCR) on the ETA and 
two whole-blood samples. ETA samples were negative 
for cytomegalovirus and respiratory syncytial virus. HSV 
IgM serology was negative. The patient was immediately 
started on acyclovir 800 mg 8-hourly intravenously ap-
proximately 1 week after the initiation of TMP-SMX and 
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The advent of HIV and AIDS has brought about many diagnostic and management challenges regarding multiple 
opportunistic infections. Pneumocystis jirovecii pneumonia (PCP) is a common presentation in patients with AIDS 
who are not on prophylaxis or highly active antiretroviral therapy (HAART). Herpes simplex 1 virus (HSV-1) is a 
ubiquitous virus that mainly causes benign disease during primary infection. However, it is known to cause severe 
pneumonia and disseminated disease in the immunocompromised.1 We present a case of HSV-1 pneumonitis and 
PCP co-infection in an HIV-positive patient with respiratory failure. To the best of our knowledge, based on Pubmed 
and Google Scholar searches, this is the first case to be reported in the English language literature.
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prednisone.  TMP-SMX and prednisone were continued 
concurrently with acyclovir.
The patient remained on maximum ventilatory support 
and died 22 days after admission. 
DisCUssion
HSV-1 may cause tracheobronchitis or pneumonitis 
and is associated with significantly increased mortality 
in critically ill patients.2 It is usually due to reactivation 
of the virus, which occurs as a result of certain stimuli 
such as fever and ultraviolet light as well as immuno-
suppression.1,2 It is a rare cause of respiratory disease in 
HIV-positive individuals, the likelihood increasing with 
progression to AIDS; it is an even rarer cause of respira-
tory infection in the immunocompetent.3  
There are several hypotheses regarding the patho- 
genesis of HSV-1 pneumonia. The virus may reach the 
lower respiratory tract through contiguous spread, as-
piration from the oropharynx or haematogenous spread 
in the presence of viraemia.1 It is usually due to reactiva-
tion and not primary disease.2,4  This was consistent with 
the findings in our patient, in whom testing for HSV IgM 
M was negative.
There are no pathognomonic clinical or radiological fea-
tures for HSV pneumonia. A high index of clinical sus-
picion with appropriate laboratory testing is required 
for the diagnosis. Clinically, patients may present with 
cough, fever, dyspnoea and hypoxaemia and failure to 
wean off the ventilator.1,5 Chest radiographs gener-
ally demonstrate a bilateral ground-glass appearance. 
Pleural effusions and patchy consolidation may also be 
present.6 The virus may be detected by viral isolation or 
PCR in broncho-alveolar lavage or endotracheal aspi-
rate specimens. However, the significance of detecting 
HSV in respiratory secretions remains controversial as 
it may represent shedding rather than active disease.1-3 
Nevertheless, the presence of HSV in respiratory secre-
tions in severely ill patients has been  associated with 
a poor outcome and prolonged  ventilation.3  The dem-
onstration of intranuclear inclusions or Cowdry type A 
bodies in biopsies is highly suggestive of active infection 
in the lung or in other tissue specimens.1 However, per-
forming a lung biopsy in a ventilated patient is challeng-
ing and associated with complications.
Our patient could not be weaned off the ventilator, and 
her condition deteriorated despite appropriate antimi-
crobial therapy for PCP, as well as steroids which are 
usually beneficial in patients with severe PCP.7,8 It has 
been reported in the literature that the presence of HSV 
in  blood  indicates the inability of the host to limit viral 
replication,  with  dissemination occurring particularly 
in immunosuppressed patients.9 HSV viraemia is typi-
cally associated with interstitial pneumonia4,10 which is 
in keeping with that observed in our patient with two 
whole blood specimens being positive for HSV-1 DNA 
by PCR.
The paucity of literature regarding the diagnosis and 
management of patients who have co-infection with 
HSV pneumonia and PCP suggests that this condition 
is either rare or under-diagnosed. Considering that both 
HSV-1 pneumonia and PCP have similar clinical and radio- 
logical findings, we would recommend that in patients 
with PCP who do not respond to appropriate therapy, 
co-infection with HSV-1 pneumonia should be exclud-
ed. The demonstration of HSV in blood and in respiratory 
samples would strongly support such a diagnosis.
It is debatable whether steroid therapy exacerbated the 
underlying HSV pneumonia, or contributed to ventilator 
dependence and overall clinical deterioration in our pa-
tient. In the absence of any other data in the literature, 
we suggest that if co-infection is suspected an approach 
would be to delay steroids for 24 - 48 hours as this im-
munosuppressive agent may exacerbate the HSV infec-
tion. If co-infection is confirmed, acyclovir can be given 
before initiation of steroids. Alternatively empiric treat-
ment with both TMP-SMX and acyclovir together with 
steroids can be initiated and therapy can be modified 
once laboratory results become available for both PCP 
and HSV. Laboratory results are usually available within 
24 - 48 hours.
The diagnosis of HSV-1 pneumonia-PCP co-infection is 
rare and management is currently speculative. The opti-
mal therapy for this dual infection remains to be deter-
mined by means of greater awareness, further research 
and clinical trials. 
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